Knight presentará en la Conferencia de Salud Jefferies 2023 en la ciudad de Nueva York

Posted on by

MONTREAL, 2 de junio de 2023 /PRNewswire/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), una compañía farmacéutica especializada líder en el mercado panamericana (ex EE.UU.), anunció hoy que Samira Sakhia, presidente y directora ejecutiva, tiene previsto realizar una presentación en…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.